3E2 mitigates tumor growth.

<p>A) Tumor volume of NXS2 tumors (n = 7; mean±SEM; *p<0.05). B) Doubling time of the each tumors (•) estimated during the four first days of the different treatments (bars: mean±SEM; *p<0.01; n = 7). C) Actuarial Morbidity curves of to tumor reaching 300 mm³ (n = 7). D) Vascular density estimated on 50 different slides on 3 different treated tumors (mean±SEM; *p<0.01; n = 3). E) Mosaic pictures by apotome microscopy stained with Alexa488-conjuguated CD31 mAb (green) and counterstained with Draq5 (bar: 500 µm).